Rezultati - Chinenye Iwuji
- Showing 1 - 6 results of 6
-
1
Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial od Glen R.B. Irving, Chinenye Iwuji, Bruno Morgan, David P. Berry, William P. Steward, Anne Thomas, Karen Brown, Lynne Howells
Izdano 2015Artigo -
2
Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway od Vicenç Ruiz de Porras, Sara Bystrup, Anna Martínez‐Cardús, Raquel Pluvinet, Lauro Sumoy, Lynne Howells, Mark I. James, Chinenye Iwuji, José Luís Manzano, Laura Layos, Cristina Bugés, Albert Abad, Eva Martinez‐Balibrea
Izdano 2016Artigo -
3
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial od Lynne Howells, Chinenye Iwuji, Glen R.B. Irving, Shaun Barber, Harriet S. Walter, Zahirah Sidat, Nicola Griffin-Teall, Raj Singh, Nalini Foreman, Samita R. Patel, Bruno Morgan, William P. Steward, Andreas J. Gescher, Anne Thomas, Karen Brown
Izdano 2019Artigo -
4
A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma od Julien Edeline, Jean‐Frédéric Blanc, Philip J. Johnson, Boris Campillo‐Gimenez, Paul J. Ross, Yuk Ting, Judy King, Richard Hubner, Kate Sumpter, Suzanne Darby, JEFF EVANS, Chinenye Iwuji, Daniel Swinson, Peter L. Collins, Kinnari Patel, Iqtedar A Muazzam, Daniel H. Palmer, Tim Meyer
Izdano 2016Artigo -
5
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy od Mark I. James, Chinenye Iwuji, Glen R.B. Irving, Ankur Karmokar, Jennifer A. Higgins, Nicola Griffin-Teal, Anne Thomas, Peter Greaves, Hong Cai, Samita R. Patel, Bruno Morgan, Ashley R. Dennison, Matthew S. Metcalfe, Giuseppe Garcea, David Lloyd, David P. Berry, William P. Steward, Lynne Howells, Karen Brown
Izdano 2015Artigo -
6
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study od John Primrose, Richard Fox, Daniel H. Palmer, Hassan Malik, Rajendra Prasad, Darius Mirza, Alan Anthony, Pippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet Wasan, Paul J. Ross, Lucy Wall, Jonathan Wadsley, JEFF EVANS, Deborah Stocken, Raaj Praseedom, Yuk Ting, Brian R Davidson, John P. Neoptolemos, Timothy Iveson, James Raftery, Shihua Zhu, David Cunningham, O. James Garden, Clive Stubbs, Juan W. Valle, John Bridgewater, John Primrose, RP Fox, Helen Morement, Oscar S.H. Chan, C. Rees, Ma Yt, Tamas Hickish, Stephen Falk, Meg Finch-Jones, Ian Pope, Pippa Corrie, Tom Crosby, S. Sothi, K Sharkland, Douglas Adamson, Lucy Wall, JEFF EVANS, John Dent, U. Hombaiah, Chinenye Iwuji, Alan Anthoney, John Bridgewater, David Cunningham, Roopinder Gillmore, Paul J. Ross, S. Slater, Harpreet Wasan, Jill Waters, Juan W. Valle, Daniel H. Palmer, Hafiz Malik, John P. Neoptolemos, Olusola Olusesan Faluyi, Kate Sumpter, U. Dernedde, S Maduhusudan, G. Cogill, Caroline Archer, Timothy Iveson, Jonathan Wadsley, Suzanne Darby, Mike Peterson, AA Mukhtar, JG Thorpe, Adrian C Bateman, D. Tsang, S. Cummins, L. Nolan, Éric Beaumont, Rajendra Prasad, D. Mirza, Deborah Stocken, Raaj Praseedom, Brian R Davidson, James Raftery, Shihua Zhu, James Garden, C Stubbs, Fareeda Y. Coxon
Izdano 2019Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Cancer
Colorectal cancer
Oxaliplatin
Curcumin
FOLFOX
Oncology
Pharmacology
Surgery
Biology
Cancer research
Chemotherapy
Folinic acid
Gastroenterology
Genetics
Randomized controlled trial
Adverse effect
Biliary tract
Biliary tract cancer
Bilirubin
Biochemistry
Biotechnology
CXC chemokine receptors
CXCL1
CXCL2
Cancer stem cell
Capecitabine
Cell culture
Chemokine